Latest California Healthline Stories
Analysis: Who Profits From Steep Medical Bills? The People Tasked With Fixing Them.
Surprise bills are just the latest weapons in a decades-long war among health care industry players over who gets to keep the fortunes generated each year from patient illness: $3.6 trillion in 2018. The practice is an outrage, yet no one in the health care sector wants to unilaterally make the type of big concessions that would change things.
Datos vs miedo: 5 respuestas que te ayudarán a medir tu riesgo con el coronavirus
Los científicos tienen más preguntas que respuestas sobre cuestiones importantes relacionadas con el coronavirus, ahora oficialmente llamado COVID-19.
Facts Vs. Fears: Five Things To Help Weigh Your Coronavirus Risk
As the numbers of coronavirus fatalities and infections rise, the threat posed by the outbreak in China can seem frightening. But public health officials say the risk in the United States is low. Experts discuss some important issues that can help U.S. residents understand how the epidemic is unfolding.
When Your Doctor Is Also A Lobbyist: Inside The War Over Surprise Medical Bills
As lawmakers consider bills to protect patients against surprise medical bills, doctors have waged a stealth on-the-ground campaign to win over members of Congress. Here’s how they did it.
Beyond Burnout: Docs Decry ‘Moral Injury’ From Financial Pressures Of Health Care
Doctors and other clinicians say they’re enduring moral injury because the business of health care interferes with patient care.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
A Guide To Following The Health Debate In The 2020 Elections
As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.
Elecciones 2020: guía para seguir el debate de salud
Precios, tipo de cobertura, formas de acceder a la atención, son algunos de los temas que ya están dominando el debate en este año electoral.
Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.